Session # P2-02-05

Comparison of non-breast and ovarian cancer phenotypes of BRCA1/2 mutation carriers across multi-gene panels

: BRCA1/2 germline mutations account for the majority of hereditary breast and ovarian cancers. Until 2013, the only way to identify individuals with BRCA mutations was through single gene testing. With multi-gene panel testing (MGPT) including BRCA1/2, BRCA mutations are being identified at an increased rate. To date, the phenotype of BRCA1/2 mutation carriers includes an increased prevalence of breast, ovarian, prostate, and pancreatic cancer, as well as melanoma. The phenotype, however, of mutation carriers identified by panel testing is not well understood.

• Authors: Michelle Jackson; Amal Yussuf; Carin Espenschied; Tripti Paudyal; Jessica Profato
• Conference: SABCS 2016
• Date: Thursday, Dec 08, 2016 7:30am - 9:00am